Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study

BackgroundInvasive micropapillary breast carcinoma (IMPC) is a relatively rare pathological type of invasive breast cancer. Little is currently known on the efficacy and safety of breast-conserving treatment (BCT, lumpectomy plus postsurgical radiation) compared with mastectomy in women diagnosed wi...

Full description

Bibliographic Details
Main Authors: Song Wang, Yiyuan Zhang, Fangxu Yin, Xiaohong Wang, Zhenlin Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.741737/full
_version_ 1818261648268328960
author Song Wang
Yiyuan Zhang
Fangxu Yin
Xiaohong Wang
Zhenlin Yang
author_facet Song Wang
Yiyuan Zhang
Fangxu Yin
Xiaohong Wang
Zhenlin Yang
author_sort Song Wang
collection DOAJ
description BackgroundInvasive micropapillary breast carcinoma (IMPC) is a relatively rare pathological type of invasive breast cancer. Little is currently known on the efficacy and safety of breast-conserving treatment (BCT, lumpectomy plus postsurgical radiation) compared with mastectomy in women diagnosed with early-stage IMPC. Accordingly, we sought to investigate the long-term prognostic differences between BCT and mastectomy in patients with T1-3N0-3M0 invasive micropapillary breast carcinoma using data from the Surveillance, Epidemiology, and End Results (SEER) database.Materials and MethodsWe retrospectively analyzed 1,203 female patients diagnosed with early-stage IMPC between 2004 and 2015 from the SEER database. The impact of different surgical approaches on patient prognosis was assessed by the Kaplan-Meier method and Cox proportional risk models.ResultsA total of 609 and 594 patients underwent mastectomy and BCT, respectively. Compared with patients who underwent a mastectomy, patients in the BCT group were older and had lower tumor diameters, lower rates of lymph nodes metastasis, and higher rates of ER receptor positivity and PR receptor positivity (p < 0.05). Kaplan-Meier plots showed that the overall survival (OS) and breast cancer-specific survival (BCSS) were higher in the BCT group than in the mastectomy group. In subgroup analysis, patients with T2 stage in the BCT group had better OS than the mastectomy group. Multivariate analysis showed no statistical difference in OS and BCSS for patients in the mastectomy group compared with the BCT group (hazard ratio (HR) = 0.727; 95% confidence interval (95% CI) 0.369–1.432, p = 0.357; HR = 0.762; 95% CI 0.302–1.923, p = 0.565; respectively). During the multivariate analysis and stratifying for the T stage, a better OS was found for patients with T2 stage in the BCT group than the mastectomy group (HR = 0.333, 95% CI: 0.149–0.741, p = 0.007). There was no significant difference in OS for patients with T1 and T3 stages between the BCT and mastectomy groups (p > 0.05).ConclusionIn women with early-stage IMPC, BCT was at least equivalent to mastectomy in terms of survival outcomes. When both procedures are feasible, BCT should be recommended as the standard surgical treatment, especially for patients with T2 disease.
first_indexed 2024-12-12T18:50:34Z
format Article
id doaj.art-11c4517612f24bddb56e64c7cfaa71f3
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-12T18:50:34Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-11c4517612f24bddb56e64c7cfaa71f32022-12-22T00:15:22ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-11-011110.3389/fonc.2021.741737741737Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based StudySong Wang0Yiyuan Zhang1Fangxu Yin2Xiaohong Wang3Zhenlin Yang4Department of Thyroid and Breast Surgery, Binzhou Medical University Hospital, Binzhou, ChinaDepartment of Reproductive Endocrinology, Affiliated Reproductive Hospital of Shandong University, Jinan, ChinaDepartment of Thyroid and Breast Surgery, Binzhou Medical University Hospital, Binzhou, ChinaDepartment of Thyroid and Breast Surgery, Binzhou Medical University Hospital, Binzhou, ChinaDepartment of Thyroid and Breast Surgery, Binzhou Medical University Hospital, Binzhou, ChinaBackgroundInvasive micropapillary breast carcinoma (IMPC) is a relatively rare pathological type of invasive breast cancer. Little is currently known on the efficacy and safety of breast-conserving treatment (BCT, lumpectomy plus postsurgical radiation) compared with mastectomy in women diagnosed with early-stage IMPC. Accordingly, we sought to investigate the long-term prognostic differences between BCT and mastectomy in patients with T1-3N0-3M0 invasive micropapillary breast carcinoma using data from the Surveillance, Epidemiology, and End Results (SEER) database.Materials and MethodsWe retrospectively analyzed 1,203 female patients diagnosed with early-stage IMPC between 2004 and 2015 from the SEER database. The impact of different surgical approaches on patient prognosis was assessed by the Kaplan-Meier method and Cox proportional risk models.ResultsA total of 609 and 594 patients underwent mastectomy and BCT, respectively. Compared with patients who underwent a mastectomy, patients in the BCT group were older and had lower tumor diameters, lower rates of lymph nodes metastasis, and higher rates of ER receptor positivity and PR receptor positivity (p < 0.05). Kaplan-Meier plots showed that the overall survival (OS) and breast cancer-specific survival (BCSS) were higher in the BCT group than in the mastectomy group. In subgroup analysis, patients with T2 stage in the BCT group had better OS than the mastectomy group. Multivariate analysis showed no statistical difference in OS and BCSS for patients in the mastectomy group compared with the BCT group (hazard ratio (HR) = 0.727; 95% confidence interval (95% CI) 0.369–1.432, p = 0.357; HR = 0.762; 95% CI 0.302–1.923, p = 0.565; respectively). During the multivariate analysis and stratifying for the T stage, a better OS was found for patients with T2 stage in the BCT group than the mastectomy group (HR = 0.333, 95% CI: 0.149–0.741, p = 0.007). There was no significant difference in OS for patients with T1 and T3 stages between the BCT and mastectomy groups (p > 0.05).ConclusionIn women with early-stage IMPC, BCT was at least equivalent to mastectomy in terms of survival outcomes. When both procedures are feasible, BCT should be recommended as the standard surgical treatment, especially for patients with T2 disease.https://www.frontiersin.org/articles/10.3389/fonc.2021.741737/fullinvasive micropapillary carcinomaSEERmastectomyBCTsurvival
spellingShingle Song Wang
Yiyuan Zhang
Fangxu Yin
Xiaohong Wang
Zhenlin Yang
Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study
Frontiers in Oncology
invasive micropapillary carcinoma
SEER
mastectomy
BCT
survival
title Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study
title_full Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study
title_fullStr Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study
title_full_unstemmed Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study
title_short Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study
title_sort survival outcomes after breast conserving therapy compared with mastectomy for patients with early stage invasive micropapillary carcinoma of the breast a seer population based study
topic invasive micropapillary carcinoma
SEER
mastectomy
BCT
survival
url https://www.frontiersin.org/articles/10.3389/fonc.2021.741737/full
work_keys_str_mv AT songwang survivaloutcomesafterbreastconservingtherapycomparedwithmastectomyforpatientswithearlystageinvasivemicropapillarycarcinomaofthebreastaseerpopulationbasedstudy
AT yiyuanzhang survivaloutcomesafterbreastconservingtherapycomparedwithmastectomyforpatientswithearlystageinvasivemicropapillarycarcinomaofthebreastaseerpopulationbasedstudy
AT fangxuyin survivaloutcomesafterbreastconservingtherapycomparedwithmastectomyforpatientswithearlystageinvasivemicropapillarycarcinomaofthebreastaseerpopulationbasedstudy
AT xiaohongwang survivaloutcomesafterbreastconservingtherapycomparedwithmastectomyforpatientswithearlystageinvasivemicropapillarycarcinomaofthebreastaseerpopulationbasedstudy
AT zhenlinyang survivaloutcomesafterbreastconservingtherapycomparedwithmastectomyforpatientswithearlystageinvasivemicropapillarycarcinomaofthebreastaseerpopulationbasedstudy